The above chart presents the market trend analysis for vgrandis pharma co.ltd. from 2024 to 2025.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2025, the company has completed 72 transactions, with a transaction quantity of 429814.95 and a transaction weight of 0.
YearTransactionsQuantityWeight
Bill of lading data
<
1/15
>
Trade date
2025/07/23
B/L No.
307602588700
Supplier
công ty cổ phần dược phẩm cpc1 hà nội
Buyers
vgrandis pharma co.ltd.
POLs
——
PODs
——
Supply area
Vietnam
Purchas area
Cambodia
Weight
——
Amount
3437
Hs code
30049099
Product tags
haljab premix
Product description
Thuốc Enterogrand. Hộp 20 ống 5ml. Lô sx 010525, NSX 28.05.25, HSD 27.05.27. TP: Bacillus subtilis 2 x 10^9cfu/5ml. CD: Điều trị và phòng ngừa rối loạn hệ vi sinh vật đường ruột. Mới 100%#&VN
Expand
Trade date
2025/07/23
B/L No.
307602588700
Supplier
công ty cổ phần dược phẩm cpc1 hà nội
Buyers
vgrandis pharma co.ltd.
POLs
——
PODs
——
Supply area
Vietnam
Purchas area
Cambodia
Weight
——
Amount
399
Hs code
30049099
Product tags
haljab premix
Product description
FOC Thuốc Enterogrand. Hộp 20 ống 5ml. Lô sx 010525, NSX 28.05.25, HSD 27.05.27. TP: Bacillus subtilis 2 x 10^9cfu/5ml. CD: Điều trị và phòng ngừa rối loạn hệ vi sinh vật đường ruột. Mới 100%#&VN
Expand
Trade date
2025/07/12
B/L No.
kpex-ef-7091-12-07-2025
vgrandis pharma co.ltd. is International Buyer&Supplier,
and primarily engages in the import and export business of products such as bat,tablet,mg tablet.
According to the 52wmb.com global trade database, as of 2025-07-23, the company has completed 883 international trades,
with its main trading regions covering india,pakistan,other etc.
The core products include HS30049099,HS30049039,HS30042000 etc,
often transported via phnom penh,port sihanoukville kompo, port sihanoukville (kompo etc,
and its main trading partners are ldd bioscience pvt ltd.,placidus pharma pvt ltd.,semos pharamaceuticals pvt ltd..
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on vgrandis pharma co.ltd. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.